Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia: Intrafamilial Variation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01386775 |
Recruitment Status :
Completed
First Posted : July 1, 2011
Last Update Posted : June 28, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Hypohidrotic Ectodermal Dysplasia |
Study Type : | Observational |
Actual Enrollment : | 64 participants |
Official Title: | Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia: Intrafamilial Variation |
Study Start Date : | June 2011 |
Actual Primary Completion Date : | July 2011 |
Actual Study Completion Date : | September 2011 |

Group/Cohort |
---|
HED Affected Males |
Controls |
- Use skin assessment techniques to characterize skin properties in male subjects affected by HED compared with healthy controls, including determination of the number of sweat ducts and the rate of sweating [ Time Frame: Day of study conduct ]Day 1
- Collecting demographic and clinical status information in male subjects affected by HED using a medical questionnaire [ Time Frame: Day of study conduct ]Study Day 1
- Assessment of intrafamilial phenotypic variability in families with multiple HED-affected male siblings [ Time Frame: Day of study conduct ]Study Day 1 - Comparison of sweat duct counts, sweat rate and hair analysis among HED-affected male siblings
- Evaluation of hair RNA profiles in samples from HED and unaffected male controls [ Time Frame: Day of study conduct ]Study Day 1 -This is a novel use of the RNASeq technology and will follow the protocol provided by an expert in the field, Dr. Benjamin Yu. The hairs will be cut not plucked from the occipital scalp, with 10-20 collected hairs placed in a regular mailing envelope. The hair-containing envelopes will be shipped to Dr. Yu's laboratory for processing and analysis.
- Confirming the presence of ectodysplasin A (EDA) gene mutations in HED subjects enrolled in this study [ Time Frame: Day of study conduct ]Study Day 1

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 1 Year and older (Child, Adult, Older Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Registered and attending the 2011 NFED Family Conference;
- One year of age or greater;
-
Conform to one of the following requirements for providing informed consent/assent:
- if more than 18 years of age, subjects must provide signed informed consent;
- if less than 18 years of age and it is determined that the subject is capable of providing assent, both the assent of the subject and consent of the parent(s) or guardian of that subject must be granted. Under this condition, both parents of the subject should give their permission, unless 1 parent is deceased, unknown, incompetent, or not available;
- if the subject is incapable of providing assent, the consent of the parent(s) or guardian of the subject must be granted. Under this condition, both parents should give their consent, unless 1 parent is deceased, unknown, incompetent, or not available.
-
As described in Section 3.2 above, subjects must meet one of the following criteria:
- Male subjects with the clinical characteristics of HED, including at least a history of decreased sweating and either abnormal teeth (fewer permanent teeth, teeth are smaller than average and often have conical crowns), and/or sparseness of scalp and body hair (Male HED subjects with an affected sibling also enrolling in the study will be given priority to be in the study);
- Healthy male controls, i.e. either unaffected male family members or unaffected male volunteers.
Exclusion Criteria:
- Known hypersensitivity to pilocarpine or pilocarpine-like muscarinic agonists;
- Known hypersensitivity to lidocaine or lidocaine like agents;
- Presence of pacemakers;
- Subjects who are not able or are not willing to comply with the procedures of this protocol;
- Subjects with any major medical problem that will prevent them from participating in this study.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01386775
United States, Illinois | |
Hilton Garden Inn St. Louis Shiloh/O'Fallon | |
O'Fallon, Illinois, United States, 62269 |
Principal Investigator: | Dorothy K Grange, MD | Washington University School of Medicine |
Responsible Party: | Edimer Pharmaceuticals |
ClinicalTrials.gov Identifier: | NCT01386775 |
Other Study ID Numbers: |
ECP-007 |
First Posted: | July 1, 2011 Key Record Dates |
Last Update Posted: | June 28, 2012 |
Last Verified: | June 2012 |
X-Linked Hypohidrotic Ectodermal Dysplasia XLHED Hypohidrotic Ectodermal Dysplasia HED |
Ectodermal Dysplasia Ectodermal Dysplasia 1, Anhidrotic Hyperplasia Pathologic Processes Abnormalities, Multiple Congenital Abnormalities |
Skin Abnormalities Skin Diseases, Genetic Genetic Diseases, Inborn Skin Diseases Genetic Diseases, X-Linked |